{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:57Z","timestamp":1786120377982,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Gastroenterology & Hepatology"],"published-print":{"date-parts":[[1997,2]]},"DOI":"10.1097\/00042737-199702000-00007","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T08:33:19Z","timestamp":1334219599000},"page":"145-147","source":"Crossref","is-referenced-by-count":1,"title":["Bile acid therapy and markers of immune-mediated damage in primary biliary cirrhosis"],"prefix":"10.1097","volume":"9","author":[{"given":"John S.","family":"de Caestecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["European Journal of Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042737-199702000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:37:46Z","timestamp":1786048666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042737-199702000-00007"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":0,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1097\/00042737-199702000-00007","relation":{},"ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":[],"published":{"date-parts":[[1997,2]]}}}